EFNB2, also known as ephrin-B2, is a transmembrane ligand that can activate Eph receptor tyrosine kinases and has been shown to promote cancer cell proliferation, invasion, and angiogenesis [33, 34]. The gene discussed is EFNB2; the disease is cancer.